Decision letter for "Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-on to Metformin in Korean Patients with Type 2 Diabetes: A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial"

View at publisher Summarise with VIRAT

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Pharmacology and Obesity Treatment

Publication details

Journal / source
Publons reviews and discussion
Publication date
4 March 2026
Language
EN